Back
The Descartes Systems Group, Inc. Vs. Kymera Therapeutics, Inc. Industry Stock Comparison
Buy
80
DSGX
The Descartes Systems Group, Inc.
Last Price:
$92.74
Seasonality Move:
14.57%
Buy
72
KYMR
Kymera Therapeutics, Inc.
Last Price:
$66.69
Seasonality Move:
7.7%
Buy
80
The Descartes Systems Group, Inc. (DSGX)
is a Buy
Is The Descartes Systems Group, Inc. a Buy, Sell or Hold?
-
The current The Descartes Systems Group, Inc. [DSGX] share price is $92.75. The Score for DSGX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
-
DSGX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
72
Kymera Therapeutics, Inc. (KYMR)
is a Buy
Is Kymera Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Kymera Therapeutics, Inc. [KYMR] share price is $66.62. The Score for KYMR is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
-
KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DSGX Stock Price Chart
What is The Descartes Systems Group, Inc.'s stock price today?
-
The The Descartes Systems Group, Inc. share price today is $92.75Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DSGX is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics, Inc.'s stock price today?
-
The Kymera Therapeutics, Inc. share price today is $66.62Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
DSGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.35 | Sell |
| Relative Strength Index (14 RSI): | 64.47 | Buy |
| Chaikin Money Flow: | -786079 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (80.07 - 87.47) | Buy |
| Bollinger Bands (100): | (87.69 - 104.37) | Sell |
KYMR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.78 | Buy |
| Relative Strength Index (14 RSI): | 60.29 | Buy |
| Chaikin Money Flow: | 254539 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.36 - 66.56) | Buy |
| Bollinger Bands (100): | (43.77 - 61.91) | Buy |
DSGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.25 | Buy |
| 20-day SMA: | 83.18 | Buy |
| 50-day SMA: | 89.5 | Buy |
| 200-day SMA: | 100.39 | Sell |
| 8-day EMA: | 86.75 | Buy |
| 20-day EMA: | 85.41 | Buy |
| 50-day EMA: | 89.03 | Buy |
| 200-day EMA: | 98.1 | Sell |
KYMR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.47 | Buy |
| 20-day SMA: | 64.83 | Buy |
| 50-day SMA: | 61.21 | Buy |
| 200-day SMA: | 43.96 | Buy |
| 8-day EMA: | 66.09 | Buy |
| 20-day EMA: | 64.75 | Buy |
| 50-day EMA: | 60.61 | Buy |
| 200-day EMA: | 48.97 | Buy |
The Descartes Systems Group, Inc. Earnings Growth & DSGX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.01 per share, an increase this year of $0.62 per share, and an increase next year of $0.26 per share.
Kymera Therapeutics, Inc. Earnings Growth & KYMR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.64 per share, and a decrease next year of $0.35 per share.
The Descartes Systems Group, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Kymera Therapeutics, Inc. Technical Analysis
| Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||